HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenji Kabashima Selected Research

Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)

5/2021Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic syndrome followed by transient palmoplantar keratoderma-like eruption.
12/2014Palmoplantar keratosis in oculodentodigital dysplasia with a GJA1 point mutation out of the C-terminal region of connexin 43.
11/2013Mutations in SERPINB7, encoding a member of the serine protease inhibitor superfamily, cause Nagashima-type palmoplantar keratosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenji Kabashima Research Topics

Disease

52Atopic Dermatitis (Atopic Eczema)
05/2022 - 08/2003
48Inflammation (Inflammations)
10/2022 - 03/2002
40Contact Dermatitis (Eczema, Contact)
01/2022 - 06/2003
28Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 11/2008
27Dermatitis
10/2022 - 05/2010
25Pruritus (Itching)
01/2022 - 02/2011
18Hypersensitivity (Allergy)
01/2022 - 08/2003
16Neoplasms (Cancer)
01/2022 - 11/2007
16Melanoma (Melanoma, Malignant)
10/2021 - 04/2010
13Skin Diseases (Skin Disease)
01/2022 - 02/2008
8Eosinophilia
05/2021 - 10/2007
8Hyperplasia
01/2021 - 07/2013
7Bullous Pemphigoid (Pemphigoid)
09/2021 - 04/2016
7Infections
01/2021 - 05/2013
7Asthma (Bronchial Asthma)
04/2020 - 08/2003
6Eczema
05/2022 - 02/2008
6Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
12/2021 - 10/2012
5Psoriatic Arthritis
11/2019 - 11/2012
5Skin Neoplasms (Skin Cancer)
01/2018 - 02/2011
4Urticaria (Hives)
01/2022 - 01/2012
4Hemangiosarcoma (Angiosarcoma)
11/2019 - 03/2014
4Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2019 - 10/2007
4Edema (Dropsy)
02/2016 - 09/2012
3Pain (Aches)
11/2021 - 10/2020
3Exanthema (Rash)
11/2021 - 10/2007
3Fever (Fevers)
11/2021 - 05/2012
3Drug Hypersensitivity Syndrome
05/2021 - 05/2014
3Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
05/2021 - 11/2013
3Warts (Wart)
01/2021 - 01/2019
3Acne Vulgaris
01/2021 - 05/2006
3Folliculitis (Sycosis)
01/2021 - 11/2012
3Alopecia Areata
06/2019 - 11/2012
3Hemorrhage
01/2019 - 09/2015
3Obesity
01/2019 - 10/2017
3Rheumatoid Arthritis
01/2019 - 12/2010
3Pemphigus (Pemphigus Vulgaris)
01/2019 - 12/2017
3Blister (Bulla)
12/2017 - 04/2016
3Chronic Urticaria
08/2017 - 12/2013
3Vasculitis (Vasculitides)
06/2016 - 03/2014

Drug/Important Bio-Agent (IBA)

24CytokinesIBA
01/2022 - 03/2002
17AntigensIBA
12/2021 - 06/2003
16NivolumabIBA
08/2022 - 01/2016
16Immunoglobulin E (IgE)IBA
01/2022 - 08/2007
16Pharmaceutical PreparationsIBA
09/2021 - 05/2006
14HaptensIBA
01/2022 - 07/2008
13Imiquimod (Aldara)FDA LinkGeneric
10/2022 - 07/2014
13ProstaglandinsIBA
12/2021 - 04/2002
13Filaggrin ProteinsIBA
01/2021 - 05/2010
12Interleukin-17 (Interleukin 17)IBA
10/2022 - 11/2008
9Proteins (Proteins, Gene)FDA Link
05/2021 - 02/2010
8ChemokinesIBA
01/2022 - 01/2008
7Interleukin-4 (Interleukin 4)IBA
12/2021 - 08/2007
7Ointments (Pastes)IBA
10/2021 - 01/2009
7Janus Kinase InhibitorsIBA
10/2021 - 12/2016
6Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 10/2016
6Histamine (Histamine Dihydrochloride)FDA Link
01/2022 - 02/2011
6Irritants (Vesicants)IBA
01/2022 - 02/2012
6delgocitinibIBA
10/2021 - 12/2016
6Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2012
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2020 - 09/2012
5OvalbuminIBA
10/2022 - 12/2004
5Histamine Antagonists (Antihistamines)IBA
01/2022 - 01/2012
5Interleukin-5 (Interleukin 5)IBA
12/2021 - 10/2010
5InterleukinsIBA
11/2021 - 01/2013
5AntibodiesIBA
01/2020 - 01/2017
5Immunoglobulin G (IgG)IBA
01/2020 - 08/2014
5LipidsIBA
06/2019 - 06/2013
5AutoantibodiesIBA
01/2019 - 04/2016
5Therapeutic UsesIBA
01/2018 - 07/2009
4Interleukin-13IBA
12/2021 - 01/2016
4Interleukin-33IBA
12/2021 - 10/2014
4Thymic Stromal LymphopoietinIBA
01/2021 - 04/2012
4IpilimumabIBA
11/2020 - 01/2018
4nemolizumabIBA
01/2020 - 01/2017
4Dinoprostone (PGE2)FDA Link
11/2019 - 01/2007
4Peptide Hydrolases (Proteases)FDA Link
07/2018 - 03/2013
4AllergensIBA
09/2015 - 08/2003
3LigandsIBA
01/2022 - 04/2010
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 - 01/2018
3SteroidsIBA
01/2022 - 09/2007
3HMGB1 Protein (HMG1)IBA
01/2022 - 09/2011
3baricitinibIBA
10/2021 - 12/2020
3Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 01/2018
3SaltsIBA
01/2021 - 01/2015
3Immune Checkpoint InhibitorsIBA
10/2020 - 10/2018
3AutoantigensIBA
01/2020 - 11/2012
3Interleukin-9 (Interleukin 9)IBA
01/2020 - 01/2016
3Indomethacin (Indometacin)FDA LinkGeneric
11/2019 - 01/2007
3Cyclin-Dependent Kinase 9IBA
08/2019 - 01/2018
3Collagen Type VIIIBA
11/2018 - 12/2012
3Tacrolimus (Prograf)FDA LinkGeneric
02/2018 - 01/2009
3Interleukin-23 (Interleukin 23)IBA
01/2018 - 07/2014
3Intravenous Immunoglobulins (IVIG)FDA Link
01/2018 - 09/2012
3Interleukin-22 (IL-22)IBA
01/2018 - 07/2014
3Methotrexate (Mexate)FDA LinkGeneric
06/2016 - 11/2012
3fexofenadine (Allegra)FDA LinkGeneric
01/2015 - 12/2012

Therapy/Procedure

34Therapeutics
05/2022 - 09/2007
7Drug Therapy (Chemotherapy)
08/2021 - 11/2007
4Immunotherapy
01/2021 - 04/2010
3Radiotherapy
10/2015 - 11/2007